A Phase 3 Study of Carfilzomib and Dexamethasone (Kd) in Patients With Relapsed and Refractory Multiple Myeloma (MM) in China

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2019)

引用 0|浏览25
暂无评分
关键词
carfilzomib,China,relapsed/refractory multiple myeloma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要